The Aroon Indicator for MDRSF entered a downward trend on November 22, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 12 similar instances where the Aroon Indicator formed such a pattern. In of the 12 cases the stock moved lower. This puts the odds of a downward move at .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MDRSF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.524) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.398) is also within normal values, averaging (43.338).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ABRFX | 15.86 | 0.25 | +1.60% |
DSS AmericaFirstMonthlyRisk-OnRisk-Off A | |||
CPEIX | 24.19 | 0.23 | +0.96% |
Catalyst Dynamic Alpha I | |||
PSSJX | 23.72 | 0.22 | +0.94% |
Principal SmallCap S&P 600 Index J | |||
FDECX | 20.88 | 0.18 | +0.87% |
Fidelity Advisor Capital Development C | |||
MBNAX | 30.41 | 0.16 | +0.53% |
NYLI Balanced Class A |
A.I.dvisor tells us that MDRSF and NHNKF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDRSF and NHNKF's prices will move in lockstep.
Ticker / NAME | Correlation To MDRSF | 1D Price Change % | ||
---|---|---|---|---|
MDRSF | 100% | N/A | ||
NHNKF - MDRSF | 28% Poorly correlated | N/A | ||
FNA - MDRSF | 24% Poorly correlated | +1.78% | ||
OSUR - MDRSF | 24% Poorly correlated | +1.93% | ||
MHUA - MDRSF | 21% Poorly correlated | +8.28% | ||
ESMC - MDRSF | 21% Poorly correlated | N/A | ||
More |